The CArdiovasCulAr Diabetes & Ethanol (CASCADE) Trial (CASCADE)


Study Type:	Interventional 
Study Design:	Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title:	Cardiovascular and Metabolic Effects of Moderate Alcohol Consumption in Type 2 Diabetes

Further study details as provided by Ben-Gurion University of the Negev:

Primary Outcome Measures: 
Glycemic control [ Time Frame: 6 months ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures: 
CVD status [ Time Frame: 6 months ] [ Designated as safety issue: Yes ]


Estimated Enrollment:	200
Study Start Date:	May 2010
Estimated Study Completion Date:	May 2012
Estimated Primary Completion Date:	May 2012 (Final data collection date for primary outcome measure)
